octaplasLG, Infusionslösung

7680006020061 CH-602 Infusionslösung

Associated product:

OCTAPLASLG groupe sanguin A sol perf 10 x 200 ml
octaplasLG, Infusionslösung
octaplasLG, Infusionslösung
octaplasLG, Infusionslösung
1 / 3
google

Article details

Package size
10x200
Selling units
10
Measure
ml
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/01/2025
Summary of Product Characteristics
Français
14/01/2025
Summary of Product Characteristics
Italien
14/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Octapharma AG

8853 Lachen SZ

Authorization information

Swissmedic authorization number
602
Drug name
octaplasLG, Infusionslösung
Galenic form
LSINF
ATC Code
B05AA
Authorization status
Z
Dispensing category
B
First authorization
20/04/1999
Authorization expiration date
31/12/9999
IT Number
06.01.1.
Domain
Human medicine
Field of application
komplexe Störungen des Hämostase-Systems ohne Möglichkeit einer differenzierten Therapie, wie z.B. Verbrauchskoagulopatie (DIC)

Package details

Description (FR)
OCTAPLASLG groupe sanguin A sol perf 10 x 200 ml
Description (DE)
OCTAPLASLG Blutgruppe A Inf Lös 10 x 200 ml
Market launch
20/04/1999
Narcotic (BTM)
No

Application methods

IV

Other package sizes (8)

None
None None
GTIN: None
Not in V1
None
200 ML
GTIN: None
Not in V1
None
200 ML
GTIN: None
Not in V1
None
200 ML
GTIN: None
Not in V1
None
200 ML
GTIN: None
Not in V1
OCTAPLASLG groupe sanguin B sol perf 10 x 200 ml
10x200 ML
GTIN: 7680006020078
View
OCTAPLASLG groupe sanguin AB sol perf 10 x 200 ml
10x200 ML
GTIN: 7680006020085
View
OCTAPLASLG groupe sanguin 0 sol perf 10 x 200 ml
10x200 ML
GTIN: 7680006020092
View